Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.02 USD | -0.41% | +10.71% | -5.70% |
30/04 | Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer | CI |
08/03 | Akero Therapeutics Raises $367 Million From Share Offering | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.70% | 1.52B | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- AKRO Stock
- News Akero Therapeutics, Inc.
- Transcript : Akero Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 09